Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh
· Delayed Price · Currency is BDT 56.20
+1.30 (2.37%)
At close: Mar 9, 2026
Navana Pharmaceuticals Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 |
| Market Capitalization | 6,037 | 5,403 | 9,377 | 12,546 | - | - | Upgrade
|
| Market Cap Growth | 26.29% | -42.38% | -25.26% | - | - | - | Upgrade
|
| Enterprise Value | 10,053 | 10,136 | 13,845 | 15,739 | - | - | Upgrade
|
| Last Close Price | 56.20 | 48.90 | 82.67 | 108.87 | - | - | Upgrade
|
| PE Ratio | 11.27 | 11.08 | 23.18 | 35.15 | - | - | Upgrade
|
| PS Ratio | 0.63 | 0.61 | 1.36 | 2.20 | - | - | Upgrade
|
| PB Ratio | 1.19 | 1.11 | 2.06 | 2.87 | - | - | Upgrade
|
| P/TBV Ratio | 1.19 | 1.11 | 2.06 | 2.87 | - | - | Upgrade
|
| P/FCF Ratio | 3.17 | 3.74 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 2.91 | 2.98 | 13.26 | 64.76 | - | - | Upgrade
|
| EV/Sales Ratio | 1.06 | 1.15 | 2.01 | 2.76 | - | - | Upgrade
|
| EV/EBITDA Ratio | 5.60 | 5.91 | 11.90 | 16.29 | - | - | Upgrade
|
| EV/EBIT Ratio | 6.86 | 7.01 | 13.96 | 20.83 | - | - | Upgrade
|
| EV/FCF Ratio | 5.27 | 7.02 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.84 | 0.96 | 1.18 | 0.99 | 0.87 | 0.45 | Upgrade
|
| Debt / EBITDA Ratio | 2.36 | 2.63 | 4.46 | 4.48 | 4.09 | 3.42 | Upgrade
|
| Debt / FCF Ratio | 2.22 | 3.22 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.80 | 0.91 | 1.10 | 0.85 | 0.80 | 0.44 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.30 | 2.58 | 4.33 | 3.85 | 4.13 | 3.69 | Upgrade
|
| Net Debt / FCF Ratio | 2.11 | 3.07 | -8.05 | -2.65 | -2.40 | -3.67 | Upgrade
|
| Asset Turnover | 0.83 | 0.78 | 0.66 | 0.68 | 0.78 | 0.75 | Upgrade
|
| Inventory Turnover | 2.36 | 2.26 | 1.96 | 2.28 | 2.47 | 2.27 | Upgrade
|
| Quick Ratio | 0.27 | 0.26 | 0.21 | 0.26 | 0.19 | 0.31 | Upgrade
|
| Current Ratio | 0.90 | 0.86 | 0.87 | 0.99 | 0.88 | 1.15 | Upgrade
|
| Return on Equity (ROE) | 11.06% | 10.35% | 9.06% | 9.09% | 8.07% | 6.31% | Upgrade
|
| Return on Assets (ROA) | 7.99% | 7.94% | 5.93% | 5.67% | 5.80% | 4.52% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.01% | 11.22% | 8.67% | 8.18% | 7.12% | 5.31% | Upgrade
|
| Return on Capital Employed (ROCE) | 26.00% | 26.70% | 19.80% | 16.00% | 15.00% | 9.60% | Upgrade
|
| Earnings Yield | 8.91% | 9.03% | 4.32% | 2.84% | - | - | Upgrade
|
| FCF Yield | 31.59% | 26.73% | -6.67% | -11.19% | - | - | Upgrade
|
| Dividend Yield | 2.55% | 2.86% | 1.69% | 1.19% | - | - | Upgrade
|
| Payout Ratio | 7.73% | 8.52% | 33.83% | 31.70% | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.56% | - | -8.05% | -23.91% | - | - | Upgrade
|
| Total Shareholder Return | 1.99% | 2.86% | -6.36% | -22.72% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.